查詢結果分析
來源資料
頁籤選單縮合
題名 | A Case Discussion of Locally Advanced Breast Cancer Enrolled in the ALTTO Trial=一位局部晚期的乳癌患者進入ALTTO臨床試驗的病例討論 |
---|---|
作者 | 張沛泓; 吳宗翰; Chang, Pei-hung; Wu, Tsung-han; |
期刊 | 臺灣癌症醫學雜誌 |
出版日期 | 20100800 |
卷期 | 26:4 2010.08[民99.08] |
頁次 | 頁170-173 |
分類號 | 416.226 |
語文 | eng |
關鍵詞 | 局部晚期乳癌; 臨床試驗; Locally advanced breast cancer; Clinical trial; |
中文摘要 | 局部晚期的乳癌和早期的乳癌病患比較起來有比較不好的預後及比較高的局部及遠端 復發率。最佳的治療通常需要多方面專家團隊如外科、腫瘤內科、放射腫瘤科醫師的合作。 對於局部晚期之乳癌病患,進入臨床試驗也許可以提供病患較好的存活率。以下報告一位 局部晚期之乳癌患者接受輔助性化學治療,之後進入臨床試驗的病例報告。 |
英文摘要 | Locally advanced breast cancer (LABC) is associated with a poorer prognosis and a higher rate of local and distant recurrence as compared to earlier stages of the disease. A multidisciplinary approach, which results from a working team of surgeons, medical oncologist, and radiation oncologist, is usually needed for the optimal treatment. Enrollment into a clinical trial may provide a better survival benefit for these patients. We report a case of LABC who receive adjuvant chemotherapy and then enrolled in a clinical trial. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。